Showing 201 - 220 results of 10,761 for search '(( 50 ((ng decrease) OR (((we decrease) OR (mean decrease)))) ) OR ( 50 μ decrease ))', query time: 0.55s Refine Results
  1. 201
  2. 202

    Protocols. by Yoichiro Kitajima (4319455)

    Published 2022
    Subjects:
  3. 203
  4. 204

    ngLVA degradation kinetics. by Nicole A. Grieshaber (11175417)

    Published 2022
    “…<p>Cos-7 cell infected with L2-euoprom-ngLVA, treated with 34 μg/ml chloramphenicol (CAM) or vehicle only (1:1000 EtOH in RPMI) at 35 hpi (arrow). …”
  5. 205
  6. 206
  7. 207
  8. 208

    Inclusion of TPP side chains result in decreased melanoma cell mitochondria membrane potential, oxygen consumption, and increased DHE oxidation. by Kyle C. Kloepping (9928265)

    Published 2020
    “…(B) Oxygen consumption rates were measured using a Seahorse Bioscience XF96 extracellular flux analyzer in A375 melanoma cells treated with or without 1.0 μM 12-TPP (N = 4). At the 25 min mark, 1.0 μM 12-TPP was added to treatment A375 cells followed by the sequential addition of 2.5 μM oligomycin at the 60 min mark, 0.3 μM oligomycin at the 90 min mark, and 5.0 μM rotenone/antimycin A at the 120 min mark. …”
  9. 209
  10. 210
  11. 211
  12. 212
  13. 213
  14. 214
  15. 215
  16. 216
  17. 217
  18. 218
  19. 219
  20. 220

    Parthenolide Derivatives as PKM2 Activators Showing Potential in Colorectal Cancer by Xingchen Liu (524190)

    Published 2021
    “…As a vital kinase in the glycolysis system, PKM2 is extensively expressed in colorectal cancer (CRC) to support the energy and biosynthetic needs. In this study, we designed a series of parthenolide (PTL) derivatives through a stepwise structure optimization, and an excellent derivate <b>29e</b> showed good activity on PKM2 (AC<sub>50</sub> = 86.29 nM) and displayed significant antiproliferative activity against HT29 (IC<sub>50</sub> = 0.66 μM) and SW480 (IC<sub>50</sub> = 0.22 μM) cells. …”